News and Updates

A new clinical trial for an oral Ebola treatment has launched in the DRC. Discover how this breakthrough could transform EVD care and outbreak response.

AI in clinical trials is evolving rapidly, but transparency is lagging. Discover why algorithmic accountability is the next frontier for clinical research.

The FDA has granted Priority Review to Intellia Therapeutics' lonvoguran ziclumeran, a CRISPR gene-editing therapy for Hereditary Angioedema (HAE).

Novartis shares face pressure following a disappointing clinical trial outcome. Explore the impact of this setback on the company's R&D and market position.

Beam Therapeutics shares updated clinical data on their innovative base editing programs, showcasing new progress in precision gene therapy for patients.

Novartis faces a turbulent week with three clinical trial failures. Read our analysis on the muscle drug setback and what it means for the company's future.

A new clinical trial shows AI matches human diagnostic accuracy so closely that patients can’t tell the difference. Discover what this means for the future.

Ascendis Pharma will reveal critical infant trial data for navepegritide at ESPE 2026, marking a key milestone for achondroplasia treatment research.

Clinical trial sites must prioritize data infrastructure before adopting AI. Learn why robust data governance is essential for successful, compliant research.

Genflow Biosciences has reached a major milestone as its SLAB gene therapy trial hits its primary endpoint, signaling a breakthrough in aging research.